Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Kestin

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
American Journal of Clinical Pathology|November 12, 2003
Wedge resection margin distances and residual adenocarcinoma in lobectomy specimensNeal S Goldstein, Monica Ferkowicz, Larry Kestin, et al.
The Journal of Urology|April 12, 2005
Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancerFrank A Vicini, Carlos Vargas, Anthony Abner, et al.
Journal of the National Cancer Institute|August 21, 2003
Limited-field radiation therapy in the management of early-stage breast cancerFrank A Vicini, Larry Kestin, Peter Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systemsScott G Williams, Tom Pickles, Larry Kestin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Comparison of IGRT registration strategies for optimal coverage of primary lung tumors and involved nodes based on multiple four-dimensional CT scans obtained throughout the radiotherapy courseNasiruddin Mohammed, Larry Kestin, Inga Grills, et al.
The Journal of Urology|February 11, 2003
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factorsAlvaro Martinez, Jose Gonzalez, William Spencer, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Addressing glucose sensitivity measured by F-18 FDG PET in lung cancers for radiation treatment planning and monitoringChing-Yee Oliver Wong, Joseph Thie, Marianne Gaskill, et al.
Seminars in Radiation Oncology|June 29, 2005
Computed tomography guided management of interfractional patient variationDi Yan, David Lockman, Alvaro Martinez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2010
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancerDaniel Krauss, Larry Kestin, Hong Ye, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiationFrank Vicini, Douglas Arthur, David Wazer, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
American Journal of Clinical Pathology|November 12, 2003
Wedge resection margin distances and residual adenocarcinoma in lobectomy specimensNeal S Goldstein, Monica Ferkowicz, Larry Kestin, et al.
The Journal of Urology|April 12, 2005
Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancerFrank A Vicini, Carlos Vargas, Anthony Abner, et al.
Journal of the National Cancer Institute|August 21, 2003
Limited-field radiation therapy in the management of early-stage breast cancerFrank A Vicini, Larry Kestin, Peter Chen, et al.
International Journal of Radiation Oncology, Biology, Physics|May 30, 2006
A multicenter study demonstrating discordant results from electronic prostate-specific antigen biochemical failure calculation systemsScott G Williams, Tom Pickles, Larry Kestin, et al.
International Journal of Radiation Oncology, Biology, Physics|June 14, 2011
Comparison of IGRT registration strategies for optimal coverage of primary lung tumors and involved nodes based on multiple four-dimensional CT scans obtained throughout the radiotherapy courseNasiruddin Mohammed, Larry Kestin, Inga Grills, et al.
The Journal of Urology|February 11, 2003
Conformal high dose rate brachytherapy improves biochemical control and cause specific survival in patients with prostate cancer and poor prognostic factorsAlvaro Martinez, Jose Gonzalez, William Spencer, et al.
International Journal of Radiation Oncology, Biology, Physics|February 14, 2006
Addressing glucose sensitivity measured by F-18 FDG PET in lung cancers for radiation treatment planning and monitoringChing-Yee Oliver Wong, Joseph Thie, Marianne Gaskill, et al.
Seminars in Radiation Oncology|June 29, 2005
Computed tomography guided management of interfractional patient variationDi Yan, David Lockman, Alvaro Martinez, et al.
International Journal of Radiation Oncology, Biology, Physics|June 30, 2010
Lack of benefit for the addition of androgen deprivation therapy to dose-escalated radiotherapy in the treatment of intermediate- and high-risk prostate cancerDaniel Krauss, Larry Kestin, Hong Ye, et al.
International Journal of Radiation Oncology, Biology, Physics|June 1, 2010
Limitations of the American Society of Therapeutic Radiology and Oncology Consensus Panel guidelines on the use of accelerated partial breast irradiationFrank Vicini, Douglas Arthur, David Wazer, et al.
Pageof 5